Benoist Stéphane, Salabert Anne-Sophie, Penna Christophe, Karoui Mehdi, Julié Catherine, Rougier Philippe, Nordlinger Bernard
Department of Surgery, Hôpital Ambroise Paré, Boulogne, France.
Surgery. 2006 Sep;140(3):396-403. doi: 10.1016/j.surg.2006.03.023. Epub 2006 Jul 27.
Prolonged systemic preoperative chemotherapy induces pathologic changes in liver parenchyma. The consequences of vascular occlusion on liver submitted to prolonged preoperative systemic chemotherapy are not known. The aim of this case-matched study was to assess which method of vascular occlusion is most appropriate for major liver resection in patients who have undergone prolonged preoperative systemic chemotherapy.
Among 305 patients who had liver resection for colorectal metastases from 1998 to 2003, 28 underwent major liver resections under portal triad clamping after more than 6 cycles of preoperative chemotherapy (TC group). These 28 patients were compared with 32 patients matched for age, sex, ASA status, number of liver metastases, type of liver resection, and type of preoperative chemotherapy, but who had major liver resection under hepatic vascular exclusion after more than 6 cycles of preoperative chemotherapy (VE group).
There was no postoperative mortality. The morbidity rate was 18% after TC and 43% after VE (P = 0.044). Pulmonary complication rate was greater after VE (31% vs 3%, P = 0.017). The transfusion rate was 50% in the TC group and 40% in the VE group (P = 0.482). Postoperative changes of liver function tests were comparable in the two groups except for the prothrombin time, which was more prolonged from day 1 (P = 0.003) to day 5 (P = 0.04) after VE.
Vascular occlusion can be used with no mortality and acceptable morbidity for major liver resection after prolonged preoperative chemotherapy. TC should be preferred to VE, permitted by the location of the neoplasm.
术前长期全身化疗会引起肝实质的病理改变。术前长期全身化疗后肝脏血管阻断的后果尚不清楚。本病例对照研究的目的是评估哪种血管阻断方法最适合接受术前长期全身化疗的患者进行肝大部切除术。
在1998年至2003年因结直肠癌肝转移行肝切除的305例患者中,28例在接受超过6个周期的术前化疗后,在门静脉三联阻断下进行了肝大部切除术(TC组)。将这28例患者与32例年龄、性别、美国麻醉医师协会(ASA)分级、肝转移灶数量、肝切除类型和术前化疗类型相匹配,但在接受超过6个周期的术前化疗后,在肝血管隔离下进行肝大部切除术的患者进行比较(VE组)。
术后无死亡病例。TC组的发病率为18%,VE组为43%(P = 0.044)。VE组的肺部并发症发生率更高(31%对3%,P = 0.017)。TC组的输血率为50%,VE组为40%(P = 0.482)。两组肝功能检查的术后变化相当,但凝血酶原时间除外,VE组术后第1天(P = 0.003)至第5天(P = 0.04)凝血酶原时间延长更明显。
术前长期化疗后进行肝大部切除术时,血管阻断可无死亡且发病率可接受。根据肿瘤位置,TC应优于VE。